BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37056049)

  • 1. Development of a translatable gene augmentation therapy for CNGB1-retinitis pigmentosa.
    Occelli LM; Zobel L; Stoddard J; Wagner J; Pasmanter N; Querubin J; Renner LM; Reynaga R; Winkler PA; Sun K; Marinho LFLP; O'Riordan CR; Frederick A; Lauer A; Tsang SH; Hauswirth WW; McGill TJ; Neuringer M; Michalakis S; Petersen-Jones SM
    Mol Ther; 2023 Jul; 31(7):2028-2041. PubMed ID: 37056049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.
    Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Becirovic E; Koch F; Seide C; Beck SC; Seeliger MW; Biel M; Mühlfriedel R; Michalakis S
    Hum Mol Genet; 2012 Oct; 21(20):4486-96. PubMed ID: 22802073
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Wagner JE; Zobel L; Gerhardt MJ; O'Riordan CR; Frederick A; Petersen-Jones SM; Biel M; Michalakis S
    Hum Gene Ther; 2021 Oct; 32(19-20):1158-1170. PubMed ID: 34376057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.
    Michalakis S; Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Schulze E; Becirovic E; Koch F; Seide C; Beck SC; Seeliger MW; Mühlfriedel R; Biel M
    Adv Exp Med Biol; 2014; 801():733-9. PubMed ID: 24664765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic and Phenotypic Characterization of a Cohort of Patients Affected by Rod Cyclic Nucleotide Channel-Associated Retinitis Pigmentosa.
    Colombo L; Bonetti G; Maltese PE; Iarossi G; Ziccardi L; Fogagnolo P; De Ruvo V; Murro V; Giorgio D; Falsini B; Placidi G; Martella S; Galantin E; Bertelli M; Rossetti L
    Ophthalmic Res; 2024; 67(1):301-310. PubMed ID: 38705136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large animal model for CNGB1 autosomal recessive retinitis pigmentosa.
    Winkler PA; Ekenstedt KJ; Occelli LM; Frattaroli AV; Bartoe JT; Venta PJ; Petersen-Jones SM
    PLoS One; 2013; 8(8):e72229. PubMed ID: 23977260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients and animal models of CNGβ1-deficient retinitis pigmentosa support gene augmentation approach.
    Petersen-Jones SM; Occelli LM; Winkler PA; Lee W; Sparrow JR; Tsukikawa M; Boye SL; Chiodo V; Capasso JE; Becirovic E; Schön C; Seeliger MW; Levin AV; Michalakis S; Hauswirth WW; Tsang SH
    J Clin Invest; 2018 Jan; 128(1):190-206. PubMed ID: 29202463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual rod function in CNGB1 mutant dogs.
    Petersen-Jones SM; Pasmanter N; Occelli LM; Querubin JR; Winkler PA
    Doc Ophthalmol; 2022 Dec; 145(3):237-246. PubMed ID: 36107278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of HCN1 enhances disease progression in mouse models of CNG channel-linked retinitis pigmentosa and achromatopsia.
    Schön C; Asteriti S; Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Herms J; Seeliger MW; Cangiano L; Biel M; Michalakis S
    Hum Mol Genet; 2016 Mar; 25(6):1165-75. PubMed ID: 26740549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNG channel-related retinitis pigmentosa.
    Gerhardt MJ; Petersen-Jones SM; Michalakis S
    Vision Res; 2023 Jul; 208():108232. PubMed ID: 37054604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired channel targeting and retinal degeneration in mice lacking the cyclic nucleotide-gated channel subunit CNGB1.
    Hüttl S; Michalakis S; Seeliger M; Luo DG; Acar N; Geiger H; Hudl K; Mader R; Haverkamp S; Moser M; Pfeifer A; Gerstner A; Yau KW; Biel M
    J Neurosci; 2005 Jan; 25(1):130-8. PubMed ID: 15634774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing Gene Therapy for PDE6A Retinitis Pigmentosa.
    Petersen-Jones SM; Occelli LM; Biel M; Michalakis S
    Adv Exp Med Biol; 2019; 1185():103-107. PubMed ID: 31884596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERG assessment of altered retinal function in canine models of retinitis pigmentosa and monitoring of response to translatable gene augmentation therapy.
    Pasmanter N; Occelli LM; Petersen-Jones SM
    Doc Ophthalmol; 2021 Oct; 143(2):171-184. PubMed ID: 33818677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripherin-2 couples rhodopsin to the CNG channel in outer segments of rod photoreceptors.
    Becirovic E; Nguyen ON; Paparizos C; Butz ES; Stern-Schneider G; Wolfrum U; Hauck SM; Ueffing M; Wahl-Schott C; Michalakis S; Biel M
    Hum Mol Genet; 2014 Nov; 23(22):5989-97. PubMed ID: 24963162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable expressivity in patients with autosomal recessive retinitis pigmentosa associated with the gene
    Radojevic B; Jones K; Klein M; Mauro-Herrera M; Kingsley R; Birch DG; Bennett LD
    Ophthalmic Genet; 2021 Feb; 42(1):15-22. PubMed ID: 33465333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory Dysfunction in Patients With CNGB1-Associated Retinitis Pigmentosa.
    Charbel Issa P; Reuter P; Kühlewein L; Birtel J; Gliem M; Tropitzsch A; Whitcroft KL; Bolz HJ; Ishihara K; MacLaren RE; Downes SM; Oishi A; Zrenner E; Kohl S; Hummel T
    JAMA Ophthalmol; 2018 Jul; 136(7):761-769. PubMed ID: 29800053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A key role for cyclic nucleotide gated (CNG) channels in cGMP-related retinitis pigmentosa.
    Paquet-Durand F; Beck S; Michalakis S; Goldmann T; Huber G; Mühlfriedel R; Trifunović D; Fischer MD; Fahl E; Duetsch G; Becirovic E; Wolfrum U; van Veen T; Biel M; Tanimoto N; Seeliger MW
    Hum Mol Genet; 2011 Mar; 20(5):941-7. PubMed ID: 21149284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa.
    Mao H; James T; Schwein A; Shabashvili AE; Hauswirth WW; Gorbatyuk MS; Lewin AS
    Hum Gene Ther; 2011 May; 22(5):567-75. PubMed ID: 21126223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal degeneration in humanized mice expressing mutant rhodopsin under the control of the endogenous murine promoter.
    Liu X; Jia R; Meng X; Li Y; Yang L
    Exp Eye Res; 2022 Feb; 215():108893. PubMed ID: 34919893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene replacement therapy for retinal CNG channelopathies.
    Schön C; Biel M; Michalakis S
    Mol Genet Genomics; 2013 Oct; 288(10):459-67. PubMed ID: 23861024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.